These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 34042280)

  • 61. New variant of acute promyelocytic leukemia with IRF2BP2-RARA fusion.
    Shimomura Y; Mitsui H; Yamashita Y; Kamae T; Kanai A; Matsui H; Ishibashi T; Tanimura A; Shibayama H; Oritani K; Kuyama J; Kanakura Y
    Cancer Sci; 2016 Aug; 107(8):1165-8. PubMed ID: 27193600
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acute promyelocytic leukaemia with a PML-RARA insertional translocation and a chromosome 21 abnormality in XYY syndrome: case report.
    He Y; Li X; Wang D; Zhang E; Hu Y; Wang W; Huang R; Xiao R
    J Int Med Res; 2014 Dec; 42(6):1363-73. PubMed ID: 25223426
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A new transcriptional variant and small azurophilic granules in an acute promyelocytic leukemia case with NPM1/RARA fusion gene.
    Kikuma T; Nakamachi Y; Noguchi Y; Okazaki Y; Shimomura D; Yakushijin K; Yamamoto K; Matsuoka H; Minami H; Itoh T; Kawano S
    Int J Hematol; 2015 Dec; 102(6):713-8. PubMed ID: 26342691
    [TBL] [Abstract][Full Text] [Related]  

  • 64. ider(17)(q10)t(15;17) associated with relapse and poor prognosis in a pediatric patient with acute promyelocytic leukemia.
    Kim MJ; Yoon HS; Cho SY; Lee HJ; Suh JT; Lee J; Yoon HJ; Lee WI; Park TS
    Cancer Genet Cytogenet; 2010 Sep; 201(2):116-21. PubMed ID: 20682396
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An Acute Promyelocytic Leukemia Resistant to All-Trans Retinoic Acid: A Case Report of the
    Castelijn DAR; Sijm G; Venniker-Punt B; Poddighe PJ; Wondergem MJ
    Case Rep Oncol; 2023; 16(1):1443-1450. PubMed ID: 38028572
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci.
    Hasan SK; Ottone T; Schlenk RF; Xiao Y; Wiemels JL; Mitra ME; Bernasconi P; Di Raimondo F; Stanghellini MT; Marco P; Mays AN; Döhner H; Sanz MA; Amadori S; Grimwade D; Lo-Coco F
    Genes Chromosomes Cancer; 2010 Aug; 49(8):726-32. PubMed ID: 20544846
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical features and treatment outcomes of pediatric acute promyelocytic leukemia in a Mexican pediatric hospital.
    Dorantes-Acosta E; Medina-Sanson A; Jaimes-García Y; López-Martínez B
    Rev Invest Clin; 2013; 65(5):392-8. PubMed ID: 24687338
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Acute Promyelocytic Leukemia with del(6)(p22) and Atypical bcr2 PML::RARA Fusion Transcript: A Case Report.
    Lauricella C; Greco R; Mancini V; Motta V; Ciraolo A; De Canal G; De Paoli E; Paglino G; Guido V; Bonoldi E; Veronese S; Soriani S
    Acta Haematol; 2023; 146(1):58-64. PubMed ID: 36198282
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Acute promyelocytic leukaemia (APML) with cryptic PML-RARA fusion has a clinical course comparable to classical APML with t(15;17)(q24.1;q21.2) translocation.
    Greenfield G; Michail O; Merron B; McGimpsey J; Catherwood M; McMullin MF
    Br J Haematol; 2019 Jul; 186(1):155-157. PubMed ID: 30585303
    [No Abstract]   [Full Text] [Related]  

  • 70. A novel NUP98-JADE2 fusion in a patient with acute myeloid leukemia resembling acute promyelocytic leukemia.
    Cheng CK; Chan HY; Yung YL; Wan TSK; Leung AWK; Li CK; Tian K; Chan NPH; Cheung JS; Ng MHL
    Blood Adv; 2022 Jan; 6(2):410-415. PubMed ID: 34673934
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia.
    Madan V; Shyamsunder P; Han L; Mayakonda A; Nagata Y; Sundaresan J; Kanojia D; Yoshida K; Ganesan S; Hattori N; Fulton N; Tan KT; Alpermann T; Kuo MC; Rostami S; Matthews J; Sanada M; Liu LZ; Shiraishi Y; Miyano S; Chendamarai E; Hou HA; Malnassy G; Ma T; Garg M; Ding LW; Sun QY; Chien W; Ikezoe T; Lill M; Biondi A; Larson RA; Powell BL; Lübbert M; Chng WJ; Tien HF; Heuser M; Ganser A; Koren-Michowitz M; Kornblau SM; Kantarjian HM; Nowak D; Hofmann WK; Yang H; Stock W; Ghavamzadeh A; Alimoghaddam K; Haferlach T; Ogawa S; Shih LY; Mathews V; Koeffler HP
    Leukemia; 2016 Aug; 30(8):1672-81. PubMed ID: 27063598
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia.
    Chim CS; Wong SY; Pang A; Chu P; Lau JS; Wong KF; Kwong YL
    Leukemia; 2005 Dec; 19(12):2241-6. PubMed ID: 16239915
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular Heterogeneity of Pediatric AML with Atypical Promyelocytes Accumulation in Children-A Single Center Experience.
    Borkovskaia A; Bogacheva S; Konyukhova T; Dadakhanova E; Gaskova M; Soldatkina O; Dubrovina M; Popov A; Mikhailova E; Inushkina E; Kazanov M; Matveev E; Novichkova G; Maschan M; Maschan A; Olshanskaya Y; Zerkalenkova E
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980947
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
    Grimwade D; Solomon E
    Curr Top Microbiol Immunol; 1997; 220():81-112. PubMed ID: 9103677
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Report of PRPF19 as a novel partner of RARG and the recurrence of interposition-type fusion in variant acute promyelocytic leukemia.
    Wu H; Li H; Zhou X; Zhao Z; Cao P; Li L; Ma X; Yuan L; Wang F; Zhang Y; Chen J; Fang J; Liu M; Liu M; Chen X; Liu H
    Hematol Oncol; 2023 Oct; 41(4):784-788. PubMed ID: 37132198
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
    Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A
    Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
    Testa U; Lo-Coco F
    Ann Hematol; 2016 Apr; 95(5):673-80. PubMed ID: 26920716
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Acute promyelocytic leukemia (AML-M3)--Part 2: Molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy.
    Randolph TR
    Clin Lab Sci; 2000; 13(2):106-16. PubMed ID: 11066449
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Variant and masked translocations in acute promyelocytic leukemia.
    Brunel V; Lafage-Pochitaloff M; Alcalay M; Pelicci PG; Birg F
    Leuk Lymphoma; 1996 Jul; 22(3-4):221-8. PubMed ID: 8819070
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rara haploinsufficiency modestly influences the phenotype of acute promyelocytic leukemia in mice.
    Welch JS; Klco JM; Varghese N; Nagarajan R; Ley TJ
    Blood; 2011 Feb; 117(8):2460-8. PubMed ID: 21190992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.